These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12892968)

  • 21. Mammographic screening from age 40 years.
    Gøtzsche PC
    Lancet; 2007 Mar; 369(9563):737-738. PubMed ID: 17336640
    [No Abstract]   [Full Text] [Related]  

  • 22. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada.
    Kopans DB; Halpern E; Hulka CA
    Cancer; 1994 Aug; 74(4):1196-203. PubMed ID: 8055437
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment uncertainties surround early diagnosis of breast cancer.
    Vanchieri C
    Ann Intern Med; 1997 Apr; 126(8):I53-4. PubMed ID: 9446506
    [No Abstract]   [Full Text] [Related]  

  • 24. Transition to digital mammography.
    Hall FM
    Radiology; 2012 Jan; 262(1):374; author reply 374. PubMed ID: 22190668
    [No Abstract]   [Full Text] [Related]  

  • 25. Swedish two-county trial: total mortality data are needed.
    Gérvas J
    Radiology; 2012 Apr; 263(1):307-8; author reply 308. PubMed ID: 22438454
    [No Abstract]   [Full Text] [Related]  

  • 26. Issues in breast cancer screening.
    Pisano E
    Technol Cancer Res Treat; 2005 Feb; 4(1):5-9. PubMed ID: 15649082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Two-County breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening.
    Jørgensen KJ; Keen JD; Zahl PH; Gøtzsche PC
    Radiology; 2012 Feb; 262(2):729-30; author reply 730-1. PubMed ID: 22282190
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mammography breast cancer screening in Italy: 2010 survey].
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):8-27. PubMed ID: 23293268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How effective are breast cancer screening programmes by mammography? Review of the current evidence.
    Schopper D; de Wolf C
    Eur J Cancer; 2009 Jul; 45(11):1916-23. PubMed ID: 19398327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The attendance of the first screening round (2002-2003) of the Hungarian organized breast cancer screening program and its effect on the number of diagnostic and screening mammography].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Csaba D; Budai A; Ember I
    Orv Hetil; 2005 Sep; 146(38):1963-70. PubMed ID: 16238249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should the hunt for nonpalpable breast lesions be called off?
    Wright CJ
    Can J Surg; 1986 Sep; 29(5):299-300. PubMed ID: 3756645
    [No Abstract]   [Full Text] [Related]  

  • 33. [Introduction of a mammography screening program in Germany. Consideration of benefits and risks].
    Nekolla EA; Griebel J; Brix G
    Radiologe; 2005 Mar; 45(3):245-54. PubMed ID: 15717183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.
    Mahnken JD; Chan W; Freeman DH; Freeman JL
    Stat Methods Med Res; 2008 Dec; 17(6):643-63. PubMed ID: 18445697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schematization and forcing of the analysis of mammographic screening effectiveness].
    Liberati A
    Epidemiol Prev; 2002; 26(2):53-4. PubMed ID: 12125384
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
    Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
    J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening.
    Buseman S; Mouchawar J; Calonge N; Byers T
    Cancer; 2003 Jan; 97(2):352-8. PubMed ID: 12518359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography and the risks of engagement.
    Pentecost MJ
    J Am Coll Radiol; 2004 Nov; 1(11):797-9. PubMed ID: 17411707
    [No Abstract]   [Full Text] [Related]  

  • 39. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
    Morrell S; Taylor R; Roder D; Dobson A
    J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: International variation in screening mammography interpretations in community-based programs.
    Onysko J; Bancej CM; Pim CP
    J Natl Cancer Inst; 2004 Feb; 96(3):238; author reply 238-9. PubMed ID: 14759996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.